Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device

Diabetes Technology and Therapeutics

Volumn 11, Issue 2, 2009, Pages 87-92

  Forst, Thomas ^a   Hohberg, Cloth ^a   Schöndorf, Thomas ^a   Borchert, Marcus ^a   Forst, Senait ^a   Roth, Werner ^a   Dehos, Barbara ^a   Pfützner, Andreas ^a  

^a Institute for Clinical Research and Development   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; RECOMBINANT HUMAN INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDICAL INSTRUMENTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATCH CLAMP; PRIORITY JOURNAL; QUESTIONNAIRE;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; ADULT; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; JUDGMENT; MALE; MIDDLE AGED; PATIENTS; RANDOM ALLOCATION;

EID: 58449106803     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0039     Document Type: Article

References (17)

1. Service FJ, Nelson RL: Characteristics of glycemic stability. Diabetes Care 1980;3:58-62.
2. Simon C, Follenius M, Brandenberger G: Postprandial oscillations of plasma glucose, insulin and C-peptide in man. Int J Obes Relat Metab Disord 1987;30:769-773.
3. Gardner DF, Arakaki RF, Podet EJ, Nell LJ, Thomas JW, Field JB: The pharmacokinetics of subcutaneous regular insulin in type I diabetic patients: assessment using a glucose clamp technique. J Clin Endocrinol Metab 1986;63:689-694.
4. Roy B, Chou MC, Field JB: Time-action characteristics of regular and NPH insulin in insulin-treated diabetics. J Clin Endocrinol Metab 1980;50:475-479.
5. Garg SK, Anderson JH, Perry SV, Mackenzie T, Keith P, Jennings MK, Hansen MM, Chase HP: Long-term efficacy of humalog in subjects with Type 1 diabetes mellitus. Diabet Med 1999;16:384-387.
6. Brunner GA, Hirschberger S, Sendlhofer G, Wutte A, Ellmerer M, Balent B, Schaupp L, Krejs GJ, Pieber TR: Postprandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus. Diabet Med 2000;17:371-375.
7. Home PD, Lindholm A, Riis A: Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial. European Insulin Aspart Study Group. Diabet Med 2000;17:762-770.
8. Rave K, Klein O, Frick AD, Becker RH: Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes. Diabetes Care 2006;29:1812-1817.
9. Rave K, Bott S, Heinemann L, Sha S, Becker RH, Willavize SA, Heise T: Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin. Diabetes Care 2005;28:1077-1082.
10. Dimitriadis GD, Gerich JE: Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 1983;6:374-377.
11. Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB: Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Diabetes Care 1995;18:1452-1459.
12. Home PD, Lindholm A, Riis A: Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial. Diabet Med 2000;17:762-770.
13. Heinemann L, Kapitza C, Starke AA, Heise T: Time-action profile of the insulin analogue B28Asp. Diabet Med 1996;13:683-684.
14. Bolli G, DiMarchi R, Park GD, Pramming S, Koivisto VA: Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 1999;42:1151-1167.
15. DeFronzo RA, Bergenstal RM, Cefalu WT, Pullman J, Lerman S, Bode BW, Phillips LS: Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care 2005;28:1922-1928.
16. Hermansen K, Ronnemaa T, Petersen AH, Bellaire S, Adamson U: Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-ofconcept trial in patients with type 2 diabetes. Diabetes Care 2004;27:162-167.
17. Jendle JH, Karlberg BE: Effects of intrapulmonary insulin in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest 1996;56:555-561.